The biotechnology company Cyclezyme reports increased revenue in the fourth quarter compared with the same period a year earlier. The operating loss decreased. The board proposes no dividend. Revenue amounted to SEK 0.7 million (0.0).Operating result was SEK -0.1 million (-0.7). Result after tax was SEK -0.1 million (-0.6). Earnings per share amounted to SEK -0.04 (-0.29). No ordinary dividend is proposed (0).Cyclezyme, SEK millionQ4-2025Q4-2024Net revenue0.70.0Operating result-0.1-0.7Net income-0.1-0.6Earnings per share, SEK-0.04-0.29Ordinary annual dividend per share, SEK00